Critics Call FDA Third-Party Social Media Guidance ‘Overbroad’-thegraysheet: Some stakeholders say a draft guidance released by FDA this summer on how manufacturers should consider interacting with third-parties online when talking about their products is overly broad and goes beyond the agency’s statutory authority. The “Guidance for Industry: Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices” states companies are not required to correct potentially misleading information posted by third parties on social media. However, they are responsible for tweets and posts that are owned, controlled, created, influenced or endorsed by them.
